Forbion Capital Partners (investor - Venture Capital)
See something wrong or missing? Let us know
Offices:Amsterdam
Forbion is a Dutch venture capital firm that works closely with entrepreneurs to build life sciences companies.
- in 2023, Forbion raises €1.35 billion across two funds both focused on focused on life sciences startups, one at an earlier stage of development and the other supporting the expansion of late-stage companies.
- in 2024, Forbion raised €2.1 billion for two new biotech funds - €1.2bn for a growth fund and €890m for an early-stage fund.
Average round investment:76.87M USD
Average number per year:6.9
Mostly invests in:
United Kingdom (14)
Health services (44)
United Kingdom (14)
Health services (44)
See the entire list
Showing 3 of 48 tracked investments in:
You need an account to access this feature. Log in or create one from here.
Do you have a question? Talk to us.
Forbion Capital Partners mostly invests with:
You need an account to access this feature. Log in or create one from here.
Do you have a question? Talk to us.
Investors with similar profile to Forbion Capital Partners
| Name | Criteria | |
|---|---|---|
![]() |
Lightspeed Venture Partners
97%
|
|
![]() |
Citigroup
97%
|
|
![]() |
Investment AB Kinnevik
96%
|
|
![]() |
British Patient Capital
96%
|
|
![]() |
Bessemer Venture Partners
96%
|
|
![]() |
Aglaé Ventures
96%
|
|
![]() |
GV
96%
|
|
![]() |
Latitude
96%
|
|
![]() |
Blossom Capital
95%
|
|
![]() |
Andera Partners
95%
|
|

GenoMines
Mosanna Therapeutics

Belgium
Austria
Germany
Denmark
Estonia
Finland
Iceland
Latvia
Lithuania
Norway
Ireland
Italy
Portugal
Spain